Deutsche Bank Ag\ Bellerophon Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.83 - $5.65 $10,969 - $16,181	-2,864 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$5.07 - $8.27 $1,368 - $2,232	-270 Reduced 8.62%	2,864 $14,000
Q4 2020 Feb 16, 2021	BUY	$6.12 - $10.37 $5,416 - $9,177	885 Added 39.35%	3,134 $21,000
Q3 2020 Nov 12, 2020	BUY	$9.27 - $13.79 $6,164 - $9,170	665 Added 41.98%	2,249 $23,000
Q2 2020 Aug 13, 2020	BUY	$9.43 - $20.28 $14,937 - $32,123	1,584 New	1,584 $20,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $573K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.